KR20210104887A - 라만 분광법을 사용하여 바이러스 역가를 측정하는 방법 - Google Patents
라만 분광법을 사용하여 바이러스 역가를 측정하는 방법 Download PDFInfo
- Publication number
- KR20210104887A KR20210104887A KR1020217023614A KR20217023614A KR20210104887A KR 20210104887 A KR20210104887 A KR 20210104887A KR 1020217023614 A KR1020217023614 A KR 1020217023614A KR 20217023614 A KR20217023614 A KR 20217023614A KR 20210104887 A KR20210104887 A KR 20210104887A
- Authority
- KR
- South Korea
- Prior art keywords
- sample
- wavenumber
- wavenumber ranges
- vip
- measured
- Prior art date
Links
- 238000001069 Raman spectroscopy Methods 0.000 title claims abstract description 133
- 241000700605 Viruses Species 0.000 title claims description 218
- 230000003612 virological effect Effects 0.000 claims abstract description 158
- 238000000034 method Methods 0.000 claims description 256
- 238000001237 Raman spectrum Methods 0.000 claims description 145
- 238000004519 manufacturing process Methods 0.000 claims description 74
- 230000003595 spectral effect Effects 0.000 claims description 48
- 238000004422 calculation algorithm Methods 0.000 claims description 38
- 239000002245 particle Substances 0.000 claims description 37
- 238000011529 RT qPCR Methods 0.000 claims description 33
- 238000005259 measurement Methods 0.000 claims description 28
- 238000010238 partial least squares regression Methods 0.000 claims description 22
- 238000012545 processing Methods 0.000 claims description 20
- 238000004458 analytical method Methods 0.000 claims description 19
- 238000011065 in-situ storage Methods 0.000 claims description 16
- 238000002965 ELISA Methods 0.000 claims description 14
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims description 14
- 230000008859 change Effects 0.000 claims description 14
- 238000007781 pre-processing Methods 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 14
- 238000003762 quantitative reverse transcription PCR Methods 0.000 claims description 14
- 208000015181 infectious disease Diseases 0.000 claims description 12
- 230000004044 response Effects 0.000 claims description 10
- 230000003044 adaptive effect Effects 0.000 claims description 8
- 238000013528 artificial neural network Methods 0.000 claims description 8
- 238000011002 quantification Methods 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 7
- 241000702421 Dependoparvovirus Species 0.000 claims description 6
- 230000001678 irradiating effect Effects 0.000 claims description 6
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 claims description 6
- 230000036961 partial effect Effects 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 4
- 206010036790 Productive cough Diseases 0.000 claims description 3
- 208000036142 Viral infection Diseases 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 3
- 210000002381 plasma Anatomy 0.000 claims description 3
- 238000004393 prognosis Methods 0.000 claims description 3
- 210000003296 saliva Anatomy 0.000 claims description 3
- 210000003802 sputum Anatomy 0.000 claims description 3
- 208000024794 sputum Diseases 0.000 claims description 3
- 210000002700 urine Anatomy 0.000 claims description 3
- 230000009385 viral infection Effects 0.000 claims description 3
- 210000003608 fece Anatomy 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 abstract description 14
- 238000011156 evaluation Methods 0.000 abstract description 13
- 239000000523 sample Substances 0.000 description 142
- 210000004027 cell Anatomy 0.000 description 33
- 238000001228 spectrum Methods 0.000 description 26
- 239000013603 viral vector Substances 0.000 description 24
- 238000004611 spectroscopical analysis Methods 0.000 description 23
- 238000012549 training Methods 0.000 description 20
- 239000013598 vector Substances 0.000 description 19
- 239000012491 analyte Substances 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 15
- 241000713666 Lentivirus Species 0.000 description 14
- 238000003556 assay Methods 0.000 description 14
- 238000001514 detection method Methods 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 230000009467 reduction Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 238000002790 cross-validation Methods 0.000 description 10
- 238000013459 approach Methods 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 230000003247 decreasing effect Effects 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 238000011068 loading method Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 238000010361 transduction Methods 0.000 description 7
- 230000026683 transduction Effects 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 6
- 238000007405 data analysis Methods 0.000 description 6
- 230000002458 infectious effect Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 5
- 238000001415 gene therapy Methods 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000004806 packaging method and process Methods 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 101000596041 Homo sapiens Plastin-1 Proteins 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- 102100035181 Plastin-1 Human genes 0.000 description 4
- 230000035508 accumulation Effects 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 239000012472 biological sample Substances 0.000 description 4
- 239000006143 cell culture medium Substances 0.000 description 4
- 238000002659 cell therapy Methods 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000010187 selection method Methods 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- 238000003146 transient transfection Methods 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 3
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
- 108010067390 Viral Proteins Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 238000013499 data model Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000011066 ex-situ storage Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000012625 in-situ measurement Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000012627 multivariate algorithm Methods 0.000 description 3
- 238000011057 process analytical technology Methods 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 108090000565 Capsid Proteins Proteins 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 238000003841 Raman measurement Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000008364 bulk solution Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001724 coherent Stokes Raman spectroscopy Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000013527 convolutional neural network Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 2
- 230000005283 ground state Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001945 resonance Rayleigh scattering spectroscopy Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 229910052594 sapphire Inorganic materials 0.000 description 2
- 239000010980 sapphire Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000004793 spatially offset Raman spectroscopy Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 210000002845 virion Anatomy 0.000 description 2
- ILMNSCQOSGKTNZ-NKWVEPMBSA-N (2r)-2-[(1r)-1-(6-aminopurin-9-yl)-2-oxoethoxy]-3-hydroxypropanal Chemical compound NC1=NC=NC2=C1N=CN2[C@H](O[C@H](CO)C=O)C=O ILMNSCQOSGKTNZ-NKWVEPMBSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 241001655883 Adeno-associated virus - 1 Species 0.000 description 1
- 241000702423 Adeno-associated virus - 2 Species 0.000 description 1
- 241001634120 Adeno-associated virus - 5 Species 0.000 description 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000012739 FreeStyle 293 Expression medium Substances 0.000 description 1
- 241001663880 Gammaretrovirus Species 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 101000596046 Homo sapiens Plastin-2 Proteins 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 101150117564 ITR2 gene Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000012124 Opti-MEM Substances 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102100035182 Plastin-2 Human genes 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 229910008760 WITec Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000013135 deep learning Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 108010027225 gag-pol Fusion Proteins Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000007758 minimum essential medium Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000012372 quality testing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000001774 stimulated Raman spectroscopy Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/44—Raman spectrometry; Scattering spectrometry ; Fluorescence spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/10—Complex mathematical operations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/12—Circuits of general importance; Signal processing
- G01N2201/129—Using chemometrical methods
- G01N2201/1293—Using chemometrical methods resolving multicomponent spectra
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/12—Circuits of general importance; Signal processing
- G01N2201/129—Using chemometrical methods
- G01N2201/1296—Using chemometrical methods using neural networks
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Data Mining & Analysis (AREA)
- Biomedical Technology (AREA)
- Theoretical Computer Science (AREA)
- Mathematical Physics (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Computational Mathematics (AREA)
- Microbiology (AREA)
- Algebra (AREA)
- Pure & Applied Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mathematical Analysis (AREA)
- Databases & Information Systems (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Mathematical Optimization (AREA)
- Software Systems (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1821206.8A GB2580186B (en) | 2018-12-24 | 2018-12-24 | Monitoring viral titre using Raman Spectroscopy |
GB1821206.8 | 2018-12-24 | ||
PCT/GB2019/053695 WO2020136376A1 (en) | 2018-12-24 | 2019-12-23 | Methods for determining viral titre using raman spectroscopy |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210104887A true KR20210104887A (ko) | 2021-08-25 |
Family
ID=65364508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020217023614A KR20210104887A (ko) | 2018-12-24 | 2019-12-23 | 라만 분광법을 사용하여 바이러스 역가를 측정하는 방법 |
Country Status (10)
Country | Link |
---|---|
US (2) | US11703455B2 (zh) |
EP (1) | EP3903096A1 (zh) |
JP (1) | JP2022515417A (zh) |
KR (1) | KR20210104887A (zh) |
CN (1) | CN113490843A (zh) |
AU (1) | AU2019412791A1 (zh) |
CA (1) | CA3123168A1 (zh) |
GB (1) | GB2580186B (zh) |
IL (1) | IL284283B1 (zh) |
WO (1) | WO2020136376A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110609030B (zh) * | 2019-10-22 | 2022-02-25 | 上海海关动植物与食品检验检疫技术中心 | 一种基于检出概率模型的拉曼快检性能综合评价方法 |
GB202010104D0 (en) * | 2020-07-01 | 2020-08-12 | Cell Therapy Catapult Ltd | Method |
US20230160829A1 (en) * | 2021-11-19 | 2023-05-25 | Janssen Biotech, Inc. | Methods for determination of virus titer in a sample using raman spectroscopy |
WO2023227438A1 (en) | 2022-05-23 | 2023-11-30 | F. Hoffmann-La Roche Ag | Raman-based method for the differentiation of aav particle serotype and aav particle loading status |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1242937A (zh) * | 1998-07-28 | 2000-02-02 | 中国科学院生物物理研究所 | 多环醌类化合物的光敏作用杀灭血制品中艾滋病毒的方法 |
US20070134733A1 (en) * | 2003-07-10 | 2007-06-14 | Parallax Biosystems, Inc. | Raman signature probes and their use in the detection and imaging of molecular processes and structures |
US20080113337A1 (en) * | 2004-11-12 | 2008-05-15 | The New Industry Research Organization | Method of Examining/Judging Presence of Virus Infection such as HIV or Presence of Prion Infection by Near-Infrared Spectroscopy and Device Used in Same |
JP2005140794A (ja) * | 2005-01-13 | 2005-06-02 | E Graw An | 化学物質および微生物の検出のためのラマンオプトロードプロセスおよび装置 |
US7889334B2 (en) * | 2005-03-15 | 2011-02-15 | University Of Georgia Research Foundation, Inc. | Surface enhanced Raman spectroscopy (SERS) systems for the detection of bacteria and methods of use thereof |
US7940387B2 (en) * | 2005-03-15 | 2011-05-10 | Univeristy Of Georgia Research Foundation, Inc. | Surface enhanced Raman spectroscopy (SERS) systems for the detection of viruses and methods of use thereof |
US20100279886A1 (en) * | 2007-04-03 | 2010-11-04 | University Of Rochester | Two-dimensional photonic bandgap structures for ultrahigh-sensitivity biosensing |
DE102008047240B4 (de) * | 2008-09-11 | 2016-03-31 | Friedrich-Schiller-Universität Jena | Verfahren zur Identifikation von Einzelviren in einer Probe |
US9662047B2 (en) * | 2010-08-05 | 2017-05-30 | Massachusetts Institute Of Technology | Portable raman diagnostic system |
TWI487910B (zh) * | 2010-09-07 | 2015-06-11 | 國立成功大學 | 倒多角錐陣列型免標定病毒檢測基板、系統及方法 |
US20120316446A1 (en) * | 2011-06-07 | 2012-12-13 | Sinisa Vukelic | Raman spectral analysis for disease detection and monitoring |
KR101523337B1 (ko) | 2012-09-20 | 2015-05-28 | 주식회사 바이오센 | 라만 분광법 및 케모메트릭스를 이용한 식물의 바이러스 감염에 대한 분석방법 |
EP3922965A3 (en) * | 2013-08-07 | 2022-03-30 | Wayne State University | Hand-held micro-raman based detection instrument and method of detection |
JP6375509B2 (ja) * | 2013-12-17 | 2018-08-22 | パナソニックIpマネジメント株式会社 | 報知装置、空気清浄機、および、報知方法 |
CN105630743B (zh) * | 2015-12-24 | 2018-05-01 | 浙江大学 | 一种光谱波数的选择方法 |
CN105603125B (zh) * | 2016-03-09 | 2019-07-12 | 华南农业大学 | 一种快速检测禽病病毒的检测试剂盒及其检测方法 |
CN108088834B (zh) * | 2017-09-13 | 2020-04-28 | 新疆大学 | 基于优化反向传播神经网络的包虫病血清拉曼光谱诊断仪 |
CN107937957B (zh) * | 2017-11-23 | 2020-05-26 | 华中农业大学 | 表面增强拉曼基底的制备方法及该基底用于检测动物病毒 |
-
2018
- 2018-12-24 GB GB1821206.8A patent/GB2580186B/en active Active
-
2019
- 2019-12-23 IL IL284283A patent/IL284283B1/en unknown
- 2019-12-23 KR KR1020217023614A patent/KR20210104887A/ko unknown
- 2019-12-23 WO PCT/GB2019/053695 patent/WO2020136376A1/en unknown
- 2019-12-23 CN CN201980092894.2A patent/CN113490843A/zh active Pending
- 2019-12-23 JP JP2021536747A patent/JP2022515417A/ja active Pending
- 2019-12-23 CA CA3123168A patent/CA3123168A1/en active Pending
- 2019-12-23 AU AU2019412791A patent/AU2019412791A1/en active Pending
- 2019-12-23 EP EP19831870.1A patent/EP3903096A1/en active Pending
- 2019-12-23 US US17/417,466 patent/US11703455B2/en active Active
-
2023
- 2023-05-26 US US18/324,728 patent/US20230384228A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2020136376A1 (en) | 2020-07-02 |
IL284283B1 (en) | 2024-03-01 |
CA3123168A1 (en) | 2020-07-02 |
CN113490843A (zh) | 2021-10-08 |
AU2019412791A1 (en) | 2021-07-08 |
US20230384228A1 (en) | 2023-11-30 |
US11703455B2 (en) | 2023-07-18 |
GB201821206D0 (en) | 2019-02-06 |
GB2580186B (en) | 2021-09-15 |
EP3903096A1 (en) | 2021-11-03 |
GB2580186A (en) | 2020-07-15 |
US20220018782A1 (en) | 2022-01-20 |
IL284283A (en) | 2021-08-31 |
JP2022515417A (ja) | 2022-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11703455B2 (en) | Methods for determining viral titre using raman spectroscopy | |
US20230236128A1 (en) | Methods for analysing viruses using raman spectroscopy | |
Li et al. | Naked-eye detection of grapevine red-blotch viral infection using a plasmonic CRISPR Cas12a assay | |
Chen et al. | Extracting chemical information from spectral data with multiplicative light scattering effects by optical path-length estimation and correction | |
Mistek et al. | Race differentiation by Raman spectroscopy of a bloodstain for forensic purposes | |
Driskell et al. | Rapid and sensitive detection of rotavirus molecular signatures using surface enhanced Raman spectroscopy | |
TW541417B (en) | Dual beam FTIR methods and devices for use in analyte detection in samples of low transmissivity | |
KR101789893B1 (ko) | 의학적 측정 곡선들을 평가하기 위한 방법 | |
Alexander | Development of methodology based on commercialized SERS-active substrates for rapid discrimination of Poxviridae virions | |
Lee et al. | Comparison of two digital PCR methods for EGFR DNA and SARS-CoV-2 RNA quantification | |
Ashton et al. | UV resonance Raman spectroscopy: a process analytical tool for host cell DNA and RNA dynamics in mammalian cell lines | |
EP1244912B1 (fr) | Evaluation d'agents biologiques dans des cellules cibles vivantes | |
Portaccio et al. | Infrared microspectroscopy characterization of gingival crevicular fluid during orthodontic treatment | |
Lu et al. | Identification of pathogens and detection of antibiotic susceptibility at single-cell resolution by Raman spectroscopy combined with machine learning | |
JP2007028978A (ja) | ヒトにおける薬物トランスポーターのmRNAの測定方法、そのためのプローブ及びキット | |
US20230160829A1 (en) | Methods for determination of virus titer in a sample using raman spectroscopy | |
Fatima et al. | Diagnosis of Hepatitis C Virus Infection in human serum using ELISA and Raman Spectroscopy | |
Olaetxea et al. | Determination of physiological lactate and pH by Raman spectroscopy | |
Portable | Early and Sensitive Detection of Pathogens for Public Health and Biosafety: An Example of Surveillance and Genotyping of SARS-CoV-2 in Sewage Water by Cas12a-Facilitated Portable Plasmonic Biosensor | |
Cao et al. | Mid-infrared spectroscopy coupled with chemometrics for quantitative determination of biomaterial activity | |
Nakar | Application of raman spectroscopy for studying bacteria of the family enterobacteriaceae | |
JPWO2022003359A5 (zh) | ||
Dietrich et al. | Raman-based PAT for VLP precipitation: systematic data diversification and preprocessing pipeline identification | |
KR20240108421A (ko) | 라만 분광법을 사용한 샘플 내 바이러스 역가 결정 방법 | |
Camp Jr et al. | Quantitative, Comparable Hyperspectral Chemical Imaging of Biological Specimens with Broadband Coherent Anti-Stokes Raman Scattering (BCARS) Microspectroscopy |